# Alveus Therapeutics, Inc. — Form D

Alveus Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-14. The offering totals $110.7M, of which $56.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2026-01-14
- Form: D
- Accession: 0001231919-26-000051
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $110.7M
- Amount sold: $56.9M
- Remaining: $53.9M
- Investors: 17
- Date of first sale: 2025-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-569872

## Issuer

- Name: Alveus Therapeutics, Inc.
- CIK: 0002075856
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 100 N. 18TH STREET, SUITE 1930, PHILADELPHIA, PA, 19103
- Phone: 215-419-7830

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Carlo de Notaristefani | Director | Philadelphia, PA |
| Ivan Gergel | Director | Philadelphia, PA |
| Garrett Ingram | Director | Philadelphia, PA |
| Raj Kannan | Director | Philadelphia, PA |
| Ameet Nathwani | Director | Philadelphia, PA |
| Claudio Nessi | Director | Philadelphia, PA |
| Gregory Parekh | Director | Philadelphia, PA |
| Jan Van de Bossche | Director | Philadelphia, PA |
| Raj Kannan | Executive Officer | Philadelphia, PA |

## More

- [CIK 2075856 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2075856&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-26-000051.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.